Charles River Laboratories CRL DSA — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's dsa — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's DSA — total revenue?
- Charles River Laboratories (CRL) reported DSA — total revenue of $596.92M in Q1 2026.
- How has Charles River Laboratories's DSA — total revenue changed year-over-year?
- Charles River Laboratories's DSA — total revenue increased by 0.7% year-over-year, from $592.61M to $596.92M.
- What is the long-term trend for Charles River Laboratories's DSA — total revenue?
- Over 2 years (2023 to 2025), Charles River Laboratories's DSA — total revenue has grown at a -4.2% compound annual growth rate (CAGR), from $2.62B to $2.4B.
- What does DSA — total revenue mean?
- The total amount of money earned by the Discovery and Safety Assessment segment from its business activities.
- How do you interpret DSA — total revenue?
- An increase indicates growing demand for research services, while a decrease suggests market contraction or loss of competitive share.
- How does DSA — total revenue compare across companies?
- Standard revenue metric across all contract research organizations (CROs).